Navigation Links
SPO Medical Reports Second Quarter 2008 Results

Company Maintains Quarterly Revenues in Challenging Marketplace

NEW YORK, August 15 /PRNewswire-FirstCall/ -- SPO Medical Inc. (OTC: SPOM - News), a leading developer of biosensor and microprocessor technologies for use in portable monitoring devices, announced its second quarter results for the period ended June 30, 2008.

Gross revenues for the period were US$1,089,000, a 1% increase over first quarter 2008 gross revenues. The Company maintained consistent gross revenue levels despite the challenging worldwide economic environment, particularly in its primary U.S. homecare market.

During the second quarter, the Company released its PulseOx 7500(TM) supporting GUI (graphic user interface) and report generation in multiple languages including French, Italian, German and Spanish ("FIGS") along with English. Additionally, the Company announced it had initiated field trials for its latest homecare wellness product using SPO's patented technology and creating a new application for the traditional home baby monitor market.

Michael Braunold, President and Chief Executive Officer of SPO Medical commented, "Despite a less than favorable macro-economic climate, we continue to introduce new products into the marketplace while expanding the distribution of our existing product line. Last quarter we were excited to announce our foray into the professional healthcare market with the introduction of two new products, the PulseOx 6000(TM) and PulseOx 6100(TM). We are pleased to report during the second quarter we witnessed an increase in sales and distribution for these new products " Mr. Braunold continued, "Additionally, the release of the enhanced PulseOx 7500(TM) supporting FIGS report generation has been received well by our European distributors."

A more detailed description of the financial results and financial statements are contained in the Company's most recent Quarterly Report on Form 10-QSB filed with the SEC.

About SPO Medical:

SPO Medical (SPOM) a leading developer of biosensor and microprocessor technologies for use in portable monitoring devices to capture life-saving and life-enhancing information within four key markets: medical care; home and remote-care; sports and wellness; and safety and security. Its patented technology uses information gathered from the reflectance of light on the human blood stream, in a non-invasive manner, to monitor key vital signs. The Company distributes its products through a network of distributors and also licenses its technologies to appropriate client corporations for commercialization and distribution. For more information, visit and

Forward Looking Statements:

This press release contains forward-looking statements that involve substantial uncertainties and risks. These forward-looking statements are based upon our current expectations, estimates and projections about our business and our industry, and that reflect our beliefs and assumptions based upon information available to us at the date of this release. We caution readers that forward-looking statements are predictions based on our current expectations about future events. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and assumptions that are difficult to predict. Our actual results, performance or achievements could differ materially from those expressed or implied by the forward-looking statements as a result of a number of factors, including but not limited to, market acceptance of our new products, changes in economic conditions generally and the medical devices market specifically, changes in technology, legislative or regulatory changes that affect us, the availability of working capital, the introduction of competing products, changes in our operating strategy or development plans and the risks and uncertainties discussed under the heading "Risk Factors" in Item 1 of our Annual Report on Form 10-KSB for the fiscal year ended December 31, 2007. We undertake no obligation to revise or update any forward-looking statement for any reason.

Investor Contacts:

SPO Medical Contact:

Michael Braunold, President and CEO

+1-866-991-SPOM (7766)

Investor Relations Contact: Howard Gostfrand / David Sasso


SOURCE SPO Medical Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
2. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
3. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
4. Pathway Medical Technologies Adds Joe Rafferty as VP, Sales, and Moves To Larger Facility to Accommodate Rapid Growth
5. BioMS Medical announces its intention to renew a normal course issuer bid
6. Dr. Amit Dhawan Promoted to Medical Director for The Mattson Jack Group
7. ATS Medical Expands Open Pivot Heart Valve Offerings
8. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
9. Globus Medical Announces Record 2nd Quarter 2007 Results
10. IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
11. China Medical Technologies Reports First Quarter Financial Results
Post Your Comments:
(Date:12/1/2015)... Dec. 1, 2015 Frost & Sullivan ... This program addresses ways companies can innovate and ... --> ... --> ... as well as the disrupting factors altering the ...
(Date:12/1/2015)... , Dec. 1, 2015  The Minnesota High Tech ... the 2015 Tekne Award in the Small and Growing ... the Minneapolis Convention Center, the ... a significant role in developing new technologies that positively ... the world. Clostridium difficile infection ( ...
(Date:12/1/2015)... 1, 2015  CardioCell LLC, a Stemedica Cell ... for cardiovascular indications, intends to proceed with finalizing ... recommendations from a Heart Failure Advisory Board comprising ... Advisory Board members . In a recent meeting ... safety and efficacy data from CardioCell,s on-going chronic ...
(Date:12/1/2015)... ... December 01, 2015 , ... RURO, ... best selling system laboratory animal colony management software solution, ezColony®, is now available ... on-site IT resources., , Many organizations are moving to ...
Breaking Biology Technology:
(Date:10/29/2015)... Oct. 29, 2015  Rubicon Genomics, Inc., today ... distribution of its DNA library preparation products, including ... new ThruPLEX Plasma-seq kit. ThruPLEX Plasma-seq has been ... of NGS libraries for liquid biopsies--the analysis of ... prognostic applications in cancer and other conditions. Eurofins ...
(Date:10/29/2015)... 29, 2015 Today, LifeBEAM , ... with 2XU, a global leader in technical performance ... hat with advanced bio-sensing technology. The hat will ... monitor key biometrics to improve overall training performance. ... two companies will bring together the most advanced technology, ...
(Date:10/27/2015)... SAN JOSE, Calif. , Oct. 27, 2015 /PRNewswire/ ... human interface solutions, today announced that Google has adopted ... family of touch controller solutions to power its newest ... Nexus 6P by Huawei. --> ... ecosystem partners like Google to provide strategic collaboration in ...
Breaking Biology News(10 mins):